[Featured Stock] SK Biopharm Hits Upper Limit for Two Consecutive Days
The SK Biopharm KOSPI listing ceremony is being held on the 2nd at the Korea Exchange in Yeouido, Seoul. Photo by Mun Ho-nam munonam@
View original image[Asia Economy Reporter Geum Bo-ryeong] SK Biopharm recorded the so-called 'ttasang' after its IPO and hit the upper price limit again the next day.
As of 9:07 a.m. on the 3rd, SK Biopharm was up 29.92% (38,000 won) from the previous close, trading at 165,000 won.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Don't Throw Away Coffee Grounds" Transformed into 'High-Grade Fuel' in Just 90 Seconds [Reading Science]
- Despite Warnings of "Do Not Enter, You May Not Make It Out Alive"... Foreign Tourist Stranded After Unauthorized Climb on Jeju Sanbangsan
- Signed Without Viewing for 1.6 Billion Won... Jamsil and Seongbuk Jeonse Prices Jump 200 Million Won in a Month [Real Estate AtoZ]
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
SK Biopharm was listed on the 2nd, the day before. On the day of listing, the opening price was 98,000 won, double the public offering price of 49,000 won, and it immediately hit the upper price limit, closing at 127,000 won to achieve 'ttasang.' 'Ttasang' means the opening price is twice the public offering price and then immediately hits the upper price limit.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
